154 related articles for article (PubMed ID: 23318477)
21. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
[TBL] [Abstract][Full Text] [Related]
22. Long-term results of ablation with antireflux surgery for Barrett's esophagus: a clinical and molecular biologic study.
Kauttu T; Räsänen J; Krogerus L; Sihvo E; Puolakkainen P; Salo JA
Surg Endosc; 2012 Jul; 26(7):1892-7. PubMed ID: 22219010
[TBL] [Abstract][Full Text] [Related]
23. High expression of Claudin-2 in esophageal carcinoma and precancerous lesions is significantly associated with the bile salt receptors VDR and TGR5.
Abu-Farsakh S; Wu T; Lalonde A; Sun J; Zhou Z
BMC Gastroenterol; 2017 Feb; 17(1):33. PubMed ID: 28212604
[TBL] [Abstract][Full Text] [Related]
24. Structural markers observed with endoscopic 3-dimensional optical coherence tomography correlating with Barrett's esophagus radiofrequency ablation treatment response (with videos).
Tsai TH; Zhou C; Tao YK; Lee HC; Ahsen OO; Figueiredo M; Kirtane T; Adler DC; Schmitt JM; Huang Q; Fujimoto JG; Mashimo H
Gastrointest Endosc; 2012 Dec; 76(6):1104-12. PubMed ID: 22831857
[TBL] [Abstract][Full Text] [Related]
25. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
[TBL] [Abstract][Full Text] [Related]
26. Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation.
Krishnan K; Pandolfino JE; Kahrilas PJ; Keefer L; Boris L; Komanduri S
Gastroenterology; 2012 Sep; 143(3):576-581. PubMed ID: 22609385
[TBL] [Abstract][Full Text] [Related]
27. Effects of Nissen fundoplication on endoscopic endoluminal radiofrequency ablation of Barrett's esophagus.
O'Connell K; Velanovich V
Surg Endosc; 2011 Mar; 25(3):830-4. PubMed ID: 20676687
[TBL] [Abstract][Full Text] [Related]
28. Significance of Nissen fundoplication after endoscopic radiofrequency ablation of Barrett's esophagus.
Skrobić O; Simić A; Radovanović N; Ivanović N; Micev M; Peško P
Surg Endosc; 2016 Sep; 30(9):3802-7. PubMed ID: 26659238
[TBL] [Abstract][Full Text] [Related]
29. Natural History of the Post-ablation Esophagus.
Reed CC; Shaheen NJ
Dig Dis Sci; 2018 Aug; 63(8):2136-2145. PubMed ID: 29671157
[TBL] [Abstract][Full Text] [Related]
30. Detection of buried Barrett's glands after radiofrequency ablation with volumetric laser endomicroscopy.
Swager AF; Boerwinkel DF; de Bruin DM; Faber DJ; van Leeuwen TG; Weusten BL; Meijer SL; Bergman JJ; Curvers WL
Gastrointest Endosc; 2016 Jan; 83(1):80-8. PubMed ID: 26124075
[TBL] [Abstract][Full Text] [Related]
31. Radiofrequency Ablation of Barrett's Esophagus: Have We Gone Too Far, or Not Far Enough?
Watts AE; Cotton CC; Shaheen NJ
Curr Gastroenterol Rep; 2020 May; 22(6):29. PubMed ID: 32383077
[TBL] [Abstract][Full Text] [Related]
32. Patterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett's esophagus.
Korst RJ; Santana-Joseph S; Rutledge JR; Antler A; Bethala V; DeLillo A; Kutner D; Lee BE; Pazwash H; Pittman RH; Rahmin M; Rubinoff M
J Thorac Cardiovasc Surg; 2013 Jun; 145(6):1529-34. PubMed ID: 23219501
[TBL] [Abstract][Full Text] [Related]
33. Neosquamous epithelium after ablation of Barrett's epithelium: cause for concern?
Dua KS; Merrill J; Komorowski R
Gastrointest Endosc; 2012 Nov; 76(5):1082-3. PubMed ID: 23078943
[No Abstract] [Full Text] [Related]
34. Endoscopic therapy using radiofrequency ablation for esophageal dysplasia and carcinoma in Barrett's esophagus.
van Vilsteren FG; Bergman JJ
Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):55-74, vi. PubMed ID: 19951794
[TBL] [Abstract][Full Text] [Related]
35. Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus.
Titi M; Overhiser A; Ulusarac O; Falk GW; Chak A; Wang K; Sharma P
Gastroenterology; 2012 Sep; 143(3):564-566.e1. PubMed ID: 22561053
[TBL] [Abstract][Full Text] [Related]
36. Toll-like Receptor 2 Signalling and the Lysosomal Machinery in Barrett's Esophagus.
Verbeek RE; Siersema PD; Vleggaar FP; Ten Kate FJ; Posthuma G; Souza RF; de Haan J; van Baal JW
J Gastrointestin Liver Dis; 2016 Sep; 25(3):273-82. PubMed ID: 27689189
[TBL] [Abstract][Full Text] [Related]
37. Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study.
van Vilsteren FG; Alvarez Herrero L; Pouw RE; Visser M; Ten Kate FJ; van Berge Henegouwen MI; Schoon EJ; Weusten BL; Bergman JJ
Endoscopy; 2012 Dec; 44(12):1096-104. PubMed ID: 23108809
[TBL] [Abstract][Full Text] [Related]
38. Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review.
Gray NA; Odze RD; Spechler SJ
Am J Gastroenterol; 2011 Nov; 106(11):1899-908; quiz 1909. PubMed ID: 21826111
[TBL] [Abstract][Full Text] [Related]
39. Effects of Lugol staining on stenosis formation induced by radiofrequency ablation of esophageal squamous epithelium: a study in a porcine model.
Schölvinck DW; Alvarez Herrero L; Visser M; Bergman JJ; Weusten BL
Dis Esophagus; 2015 Oct; 28(7):603-11. PubMed ID: 24712765
[TBL] [Abstract][Full Text] [Related]
40. Barrett's esophagus: the American perspective.
Spechler SJ
Dig Dis; 2013; 31(1):10-6. PubMed ID: 23797117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
